Tavia and Vita sign LOI for $450 million NASDAQ listing
Tavia Acquisition Corp. and Vita Inclinata Technologies, Inc. signed a non-binding LOI for a business combination to take Vita public via a de-SPAC, valuing it at a $450 million pre-money enterprise value. The transaction, expected to close in Q4 2026, is contingent on Vita completing a strategic acquisition and securing definitive agreements. Cohen & Company Capital Markets and EarlyBirdCapital are advising Tavia, while Greenberg Traurig LLP and Reed Smith LLP are providing legal counsel.

*this image is generated using AI for illustrative purposes only.
Tavia Acquisition Corp. (NASDAQ: TAVI) and Vita Inclinata Technologies, Inc. have signed a non-binding Letter of Intent (LOI) for a business combination that would result in Vita becoming a publicly traded company through a de-SPAC transaction. The proposed transaction values Vita at a pre-money enterprise value of $450 million, assuming the company successfully completes a pending strategic acquisition within the defense and industrials market. The announcement reflects Vita's continued momentum and represents an important step in the company's evolution as it prepares for its next phase of growth.
Transaction Details and Timeline
Tavia expects to execute a definitive agreement within the next 30 days, with a closing anticipated in the fourth quarter of 2026. The parties have agreed to a 45-day exclusivity period to undertake due diligence and negotiate a definitive Business Combination Agreement. In connection with the LOI, Tavia and Vita are engaged in initial non-binding investment indications from institutional investors and strategic partners. Firm commitments from these investors will be announced concurrently with the signing of a definitive agreement.
Strategic Rationale
Caleb Carr, Chief Executive Officer of Vita Inclinata Technologies, stated that access to public markets will strengthen the company's ability to invest in innovation and expand its portfolio. Kanat Mynzhanov, Chief Executive Officer and Chairman of Tavia Acquisition Corp., highlighted Vita's distinctive business and disciplined execution as key factors for the proposed combination.
Advisory Roles
Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, is acting as lead financial advisor and capital markets advisor to Tavia. EarlyBirdCapital is also serving as capital markets advisor to Tavia. Greenberg Traurig LLP is legal counsel to Vita, while Reed Smith LLP is legal counsel to Tavia.
| Entity | Role |
|---|---|
| Cohen & Company Capital Markets | Lead Financial Advisor to Tavia |
| EarlyBirdCapital | Capital Markets Advisor to Tavia |
| Greenberg Traurig LLP | Legal Counsel to Vita |
| Reed Smith LLP | Legal Counsel to Tavia |
What specific defense and industrial targets is Vita pursuing to satisfy the $450 million valuation condition?
How will the extended closing timeline of Q4 2026 impact Tavia's trust fund value and redemptions?
Which institutional investors have provided initial non-binding indications for the PIPE transaction?





















